![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
November 24, 2021
BURLINGTON, Ontario – November 24, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of one million QuickStrip™ units to one of Canada’s largest cannabis companies. Three unique formulations...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
November 9, 2021
Rapid Dose Therapeutics Completes Significant Shipment of QuickStrip™ Products to Thrive Cannabis BURLINGTON, Ontario – November 9, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has completed a significant shipment of more than 500,000...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
October 1, 2021
FOR IMMEDIATE RELEASE RDT branded QuickSips™ and QuickStrip™ will be available in stores from coast-to-coast BURLINGTON, Ontario – October 1, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced the successful receipt...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
September 28, 2021
Productive discussion regarding “made-in-Ontario COVID-19 vaccine candidate” BURLINGTON, Ontario – September 28, 2021- Yesterday afternoon, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) welcomed Premier Doug Ford and Caucus member Stephen Crawford MPP, to their head office and manufacturing facility in Burlington, Ontario...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
September 15, 2021
Pre-clinical testing has demonstrated manufacturing stability and statistically significant antibody production BURLINGTON, Ontario – September 15, 2021- Today, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMaster”) are reporting a preliminary, yet significant milestone in the investigation of an orally...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
August 26, 2021
FOR IMMEDIATE RELEASE BURLINGTON, Ontario – August 25, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), today reported its Q1 financial results. “The Company is on a path of transformation and is well-positioned to drive innovation and our business plan forward as...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
August 26, 2021
FOR IMMEDIATE RELEASE BURLINGTON, Ontario – August 25, 2021- Rapid Dose Therapeutics Corp. (“RDT” or the“Company”) (CSE: DOSE), today reported its financial results for the year ended February 28, 2021. “The Company achieved a number of key milestones this year, is transitioning efficiently into its...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
August 10, 2021
TORONTO, ONTARIO, August 10, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
July 30, 2021
BURLINGTON, Ontario July 30, 2021 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), announces, pursuant to its Stock Option Plan, the granting of incentive stock options to purchase 2,100,000 common shares at an exercise price of $0.65 per share. Each has a...
![](https://rapid-dose.com/wp-content/uploads/2017/09/RDT_med_logo.png)
July 27, 2021
TORONTO, ONTARIO, July 27, 2021 – Rapid Dose Therapeutics Corp. (the “Company”) (CSE: DOSE) is providing a bi-weekly update on the status of the management cease trade order granted on June 29, 2021 (the “MCTO”) by its principal regulator, the Ontario Securities Commission, in accordance...